Clearing and protecting pharmaceutical trademarks presents a host of challenges unique to this industry. Minimizing the risk of brand confusion isn’t just a matter of consumer convenience—it is critical for protecting patient safety. In this webinar, two experienced trademark practitioners examine the complexities of the pharma trademark process and how trademark professionals can minimize the risk of rejection.
Topics Include:
Maury Tepper is a respected practitioner of intellectual property law and board certified specialist in trademark law, with particular experience serving pharmaceutical clients. He has served on the Trademark Public Advisory Committee to the U.S. Patent and Trademark Office, and served as Counsel to INTA.
Emmanuelle Ragon joined Sanofi in 2001. Since 2008, she has led the trademarks, domain names, and copyright team with the goal to build efficient strategies for the selection, protection and enforcement of healthcare trademarks. Before Sanofi, she started her career in a dairy food company.